Description
Trade name:
Nasostop
Compound:
Each 1 ml contains:
Xylometazoline hydrochloride 0.5 mg.
Properties:
A vasoconstrictor for local use in ENT practice. When applied to mucous membranes, it causes vasoconstriction, resulting in a decrease in local hyperemia and edema. In rhinitis, it facilitates nasal breathing.
Indications:
Symptomatic treatment of nasal congestion in chronic, year-round and acute rhinitis (including allergic and pollen-related), sinusitis.
Method of administration and dosage:
Intranasally. For children aged 6 to 12 years, 1-2 drops in each nasal passage 1-2 times a day.
Contraindications:
– Individual intolerance to the components of the drug.
-Patients with a history of pituitary gland removal or other brain surgeries.
– Children under 6 years old.
– Closed-angle glaucoma.
– Atrophic rhinitis.
– Arterial hypertension, tachycardia, severe atherosclerosis.
– Hyperthyroidism.
– Diabetes mellitus.
– Pheochromatytoma.
– Inflammation of the skin and mucous membranes of the nasal vestibule.
Precautions:
The drug should not be used in children without consulting a specialist for more than 5 days to avoid atrophy of the nasal mucosa.
Side effects:
With frequent and/or prolonged use: irritation of the mucous membrane, burning, tingling, sneezing, dryness of the nasal mucosa, hypersecretion.
Rare: swelling of the nasal mucosa (more common with prolonged use), palpitations, heart rhythm disturbances, increased blood pressure, headache, vomiting, sleep disorders, visual disturbances.
With prolonged use in high doses: depressive state.
Storage method:
Store at a temperature not exceeding 30 degrees
Package:
The cardboard box contains a 15 ml dropper bottle and paper instructions.
